Section Arrow
NAUT.NASDAQ
- Nautilus Biotechnolgy
Quotes are at least 15-min delayed:2026/08/02 17:13 EDT
Regular Hours
Last
 0.977
-0.053 (-5.15%)
Day High 
1.06 
Prev. Close
1.03 
1-M High
2.065 
Volume 
925.04K 
Bid
0.977
Ask
1.02
Day Low
0.95 
Open
1.02 
1-M Low
Market Cap 
131.07M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.52 
20-SMA 1.64 
50-SMA 2.06 
52-W High 4.3101 
52-W Low 0.62 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.45/-0.76
Enterprise Value
157.26M
Balance Sheet
Book Value Per Share
1.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
REPLReplimune Group11.2+5.79+107.02%-- 
GOSSGossamer Bio0.1695-0.0088-4.94%-- 
JUNSJupiter Neurosciences Inc0.09-0.0075-7.69%-- 
KPTIKaryopharm Therapeutics Inc.1.92-5.09-72.61%-- 
IOVAIovance Biotherapeutics4.07-0.62-13.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.